Newer Drug Could Be Advance Against Tough-to-Treat Breast Cancers
FRIDAY, Dec. 13, 2024 (HealthDay News) — An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug, imlunestrant, improved progression-free survival in patients whose breast cancer was driven by the female hormone estrogen. TheContinue Reading